Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: An atherogenic link?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 9, 1997, Pages 1780-1785

  Nieto, F Javier ^a   Sorlie, Paul ^b   Comstock, George W ^a   Wu, Kenneth ^c   Adam, Erwin ^d   Melnick, Joseph L ^d   Szklo, Moyses ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atheroselerosis; Cytomegalovirus; Fibrinogen; Hemostasis; Lipoprotein(a)

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; FIBRINOGEN; LIPOPROTEIN A;

ADULT; ANTIBODY TITER; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD CHEMISTRY; CASE CONTROL STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0030823328     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.9.1780     Document Type: Article

References (16)

1. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med. 1978;148:335-3-40.
2. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME. High level of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 1987;2:291-293.
3. Melnick JL, Adam E, DeBakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA. 1990;263:2204-2207.
4. Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE, Barnes R, Melnick JL for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study. J Med Virol 1994;42:33-37.
5. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, Szklo M. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation. 1996;94:922-927.
6. Bruggeman CA, Debie WHM, Muller AD, Schutte B, van Dam-Mieras MCE. Cytomegalovirus alters the von Willebrand factor content in human endothelial cells. Thrombosis Haemost. 1988;59:264-268.
7. van Dam-Mieras MCE, Muller AD, van Hinsbergh VWM, Mullers WJHA, Bomans PHH, Bruggeman CA. The procoagulant response of cytomegalovirus infected endothelial cells. Thrombosis Haemost. 1992;68:364-370.
8. Kaner RJ, Hajjar DP. Viral activation of thrombo-atherosclerosis. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, PA: Lippincott-Ravcn, 1996:569-584.
9. The ARIC investigators. The Atherosclerosis Risk In Communities (ARIC) study: design and objectives. Am J Epidemiol. 1989;129:687-702.
10. Comstock GW, Bush TL, Helzlsouer KJ, Huffman SC. The Washington County Training Center: an exemplar of public health research in the field. Am J Epidemiol. 1991;134:1023-1029.
11. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
12. Matson DO, Adler-Storthz K, Adam E, Dreesman OR. A micro solid-phase radioimmunoassay for detection of herpesvirus type-specific antibody: parameters involved in standardization. J Virol Methods. 1983;6:71-83.
13. Adler-Storthz K, Matson DO, Adam E, Dreesman GR. A micro solid-phase radioimmunoassay for detection of herpesvirus type-specific antibody: specificity and sensitivity. J Virol Methods. 1983;6:85-97.
14. Gaubatz JW, Chari MV, Nava ML, Guyton JR, Morriset JD. Isolation and characterization of the two major apoproteins in human lipoprotein(a). J Lipid Res. 1987;28:69-79.
15. Pap AC, Hatzakis H, Bracey A, Wu KK. ARIC hemoslasis study - I: development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989;61:15-19.
16. Wu KK, Pap AC, Patsch W, Rock R, Eckfeldt J, Sharrett R. ARIC hemostasis study-II. Organizational plan and feasibility study. Thromb Haemost. 1990;64:521-525.